Recurrent Glioblastoma Multiforme (GBM) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 144 pages | ID: R7DBC133C36EN
VPAResearch

Abstracts

Recurrent Glioblastoma Multiforme (GBM) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Recurrent Glioblastoma Multiforme (GBM) disease clinical trials. The research work analyzes the ongoing Recurrent Glioblastoma Multiforme (GBM) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Recurrent Glioblastoma Multiforme (GBM) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Recurrent Glioblastoma Multiforme (GBM) clinical trials.

Scope of the Report-

• Ongoing Recurrent Glioblastoma Multiforme (GBM) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Recurrent Glioblastoma Multiforme (GBM)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Recurrent Glioblastoma Multiforme (GBM) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Recurrent Glioblastoma Multiforme (GBM) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials by Phase
3.2 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials by Type
3.3 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials
4.2 Top 10 Countries conducting Recurrent Glioblastoma Multiforme (GBM) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials by Sponsor Type
5.2 Recurrent Glioblastoma Multiforme (GBM) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Recurrent Glioblastoma Multiforme (GBM) Trials by year
6.2 Subjects Recruited for Recurrent Glioblastoma Multiforme (GBM) Trials by Phase
6.3 Subjects Recruited for Recurrent Glioblastoma Multiforme (GBM) Trials by Trial Type
6.4 Subjects Recruited for Recurrent Glioblastoma Multiforme (GBM) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials- Phase
7.2 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials- Phase
7.3 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials- Phase
7.4 Ongoing Recurrent Glioblastoma Multiforme (GBM) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Country
Figure 2: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Phase of Development, 2018
Figure 3: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Status, 2018
Figure 4: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Type, 2018
Figure 5: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials Split by Region, 2000-2018
Figure 6: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Type of Economy, 2018
Figure 7: Recurrent Glioblastoma Multiforme (GBM)- Enrolment by Phase, 2018
Figure 8: Recurrent Glioblastoma Multiforme (GBM)- Enrolment by Trial Type, 2018
Figure 9: Recurrent Glioblastoma Multiforme (GBM)- Enrolment by Recruitment Status, 2018
Figure 10: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Sponsor Type, 2018
Figure 11: Recurrent Glioblastoma Multiforme (GBM)- Enrolment by Type of Sponsors
Figure 12: Recurrent Glioblastoma Multiforme (GBM)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Sponsor Type, 2018
Table 2: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Economy Type, 2018
Table 3: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials by Region, 2018
Table 4: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Recurrent Glioblastoma Multiforme (GBM)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Recurrent Glioblastoma Multiforme (GBM)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Recurrent Glioblastoma Multiforme (GBM)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Recurrent Glioblastoma Multiforme (GBM)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Recurrent Glioblastoma Multiforme (GBM)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company